AngioDynamics (ANGO) Tops Q1 EPS by 2c, Updates Guidance

AngioDynamics (NASDAQ: ANGO) reported Q1 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $77 million versus the consensus estimate of $71.31 million.

GUIDANCE:

AngioDynamics sees FY2022 EPS of $0.00-$0.05, versus the consensus of $0.04. AngioDynamics sees FY2022 revenue of $310-315 million, versus the consensus of $307.8 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
• Stifel downgrades Intuit to Hold on growth concerns, cuts target price